Clinical Research

Enzo Biochem (NYSE:ENZ) and Personalis (NYSE:PSNL) Head-To-Head Review | 9/17/2019

Personalis has lower revenue, but higher earnings than Enzo Biochem. Enzo Biochem Company Profile Enzo Biochem, Inc., an integrated diagnostic bioscience company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates in three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment manufactures, develops, and markets products and tools to clinical research, drug development, and …

[email protected]@ Principles and Practice of Clinical Research book ‘Full_Pages’ 421 | 9/17/2019

Principles and Practice of Clinical Research book Download at = https://downloadpdfkumida.blogspot.com/0123821673 Principles and Practice of Clinical Research book pdf download, Principles and Practice of Clinical Research book audiobook download, Principles and Practice of Clinical Research book read online, Principles and Practice of Clinical Research book epub, Principles and Practice of Clinical Research book pdf full ebook, Principles and Practice of Clinical Research book amazon, Principles and Practice of Clinical …

Follow Clinical Research:    

Pittsburgh Companies Partner on Life Science Clinical Development | 9/16/2019

… MediTechnix Incorporated and Clinical Research Strategies LLC, a boutique contract research organization (CRO), have announced a strategic partnership in life science clinical development that addresses software as a medical device (SaMD), wearables, blockchain, and digital health applications in conjunction with IND-enabling development programs of drugs or biologics, and IDE-enabling development programs of medical devices. In response to the newer regulations in digital health, life science companies are evaluating …

Chain Florey Clinical Research Fellowships | Nature | 9/16/2019

Chain Florey Clinical Research Fellowships Imperial College London (ICL) Posted about 3 hours ago Expires on October 28, 2019 Job Title: Chain Florey Clinical Research Fellowships Department/Division/Faculty: Faculty of Medicine, Institute of Clinical Sciences/ MRC LMS Salary: £32,478 – £57,444 p.a., plus £2,162 London Allowance p.a. (or £26,614 – £46,208 per annum, plus £2,162 London Allowance per annum if the successful applicant has transitioned to the new junior doctor pay …

Dermatologist Dr. Rachel Cetta joins North Valley Dermatology Peoria, now a part of U.S. Dermatology Partners | PRWeb | 9/16/2019

Dr. Cetta obtained her undergraduate and master’s degree at Arizona State University before receiving her medical degree at Midwestern University College of Osteopathic Medicine in Glendale Arizona, in 2015. She then went on to complete her traditional rotating internship and dermatology residency at Beaumont Hospital in Trenton, Michigan. She joins North Valley Dermatology in Peoria, now a part of U.S. Dermatology Partners. While at Midwestern University, Dr. Cetta was awarded …

hyperCORE International Teams with VirTrial to Become First ‘Virtual Trial Capable’ Site Network in the World | PRWeb | 9/16/2019

… yet another demonstration of our commitment.” For more information on the Virtual Trial Capable certificate program, go to https://virtrial.com/research-sites/ . About VirTrial VirTrial is a technology company using a stable, long-standing telehealth platform to transform the clinical trials industry. The platform offers a patient management program that combines video, text, and email allowing pharmaceutical companies and CROs to create patient centric trials by replacing some study visits …

Shimmer Announces Launch of Open Source Initiative for Wearable Sensor Algorithm | 9/16/2019

… author of the GGIR software and algorithms for movement sensor calibration, sensor wear detection, and signal aggregation, and Nextbridge Health, which is developing the Nextbridge Exchange, an online marketplace and discovery platform for the clinical research community. Read more Shimmer Launches Verisense™ Wearable Sensor Platform for Clinical Trials “We are excited to be working with Dr. Vincent van Hees and Nextbridge on this initiative. Vincent’s GGIR platform sets the standard …

Ethical & Regulatory Aspects of Clinical Research Session 4: Fair Subject Selection, Recruitment and Retention, and Participant Panel | National Institutes of Health | 9/16/2019

Wednesday, October 23, 2019, 8:30:00 AM Time displayed is Eastern Time, Washington DC Local iCalendar: Add an upcoming event to your calendar. Description: The Department of Bioethics offers this seven to eight week course annually each fall. The course is designed to provide an overview of the important issues in the ethics of human subject research for clinical investigators and others who participate in the conduct of research and is …

Ethical & Regulatory Aspects of Clinical Research Session 7: Ethics of Genetics Research and Incidental Findings, and Ethical Issues in All of Us | National Institutes of Health | 9/16/2019

Wednesday, November 13, 2019, 8:30:00 AM Time displayed is Eastern Time, Washington DC Local iCalendar: Add an upcoming event to your calendar. Description: The Department of Bioethics offers this seven to eight week course annually each fall. The course is designed to provide an overview of the important issues in the ethics of human subject research for clinical investigators and others who participate in the conduct of research and is …

Ethical & Regulatory Aspects of Clinical Research Session 6: Ethical Issues in International Research | National Institutes of Health | 9/16/2019

Wednesday, November 6, 2019, 8:30:00 AM Time displayed is Eastern Time, Washington DC Local iCalendar: Add an upcoming event to your calendar. Description: The Department of Bioethics offers this seven to eight week course annually each fall. The course is designed to provide an overview of the important issues in the ethics of human subject research for clinical investigators and others who participate in the conduct of research and is …

Ethical & Regulatory Aspects of Clinical Research Session 5: Informed Consent, Research with Those with Impaired Capacity for Consent, and Research Ethics Consultation | National Institutes of Health | 9/16/2019

Wednesday, October 30, 2019, 8:30:00 AM Time displayed is Eastern Time, Washington DC Local iCalendar: Add an upcoming event to your calendar. Description: The Department of Bioethics offers this seven to eight week course annually each fall. The course is designed to provide an overview of the important issues in the ethics of human subject research for clinical investigators and others who participate in the conduct of research and is …

Ethical & Regulatory Aspects of Clinical Research Session 3: Ethics of Pragmatic Trials, Ethics of Randomized Clinical Trials, and Ethics of Vaccine Research | National Institutes of Health | 9/16/2019

Wednesday, October 16, 2019, 8:30:00 AM Time displayed is Eastern Time, Washington DC Local iCalendar: Add an upcoming event to your calendar. Description: The Department of Bioethics offers this seven to eight week course annually each fall. The course is designed to provide an overview of the important issues in the ethics of human subject research for clinical investigators and others who participate in the conduct of research and is …

Ethical & Regulatory Aspects of Clinical Research Session 2: IRBs, Risks and Benefits, and the Ethics of Research with Children | National Institutes of Health | 9/16/2019

Wednesday, October 2, 2019, 8:30:00 AM Time displayed is Eastern Time, Washington DC Local iCalendar: Add an upcoming event to your calendar. Description: The Department of Bioethics offers this seven to eight week course annually each fall. The course is designed to provide an overview of the important issues in the ethics of human subject research for clinical investigators and others who participate in the conduct of research and is …

Health Decisions Receives 4th Consecutive Appointment as Statistical and Clinical Coordinating Center for the Contraceptive Clinical Trials Network of the NICHD | PR Newswire | 9/16/2019

DURHAM, N.C. Health Decisions, Inc., a full-service contract research organization specializing in women’s health clinical research and diagnostic development, announced that it has been retained as the Statistical and Clinical Coordinating Center (SCCC) for the Contraceptive Clinical Trials Network (CCTN) of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a unit of the National Institutes of Health (NIH). This is Health Decisions’ fourth consecutive …

Hyundai Hope On Wheels Presents Children’s Hospital Los Angeles With $300,000 Hyundai Scholar Hope Grant To Support Pediatric Cancer Research | PR Newswire | 9/16/2019

LOS ANGELES , Sept. 16, 2019 /PRNewswire/ – Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyundai and its U.S. dealers, announces $300,000 Hyundai Scholar Hope Grant to Children’s Hospital Los Angeles (CHLA) to continue its long-standing fight against pediatric cancer. HHOW has committed $13.2 million to support 52 new doctor-researchers in their research for better treatment options and to improve care for children …

Spotlight on Acne | 9/16/2019

Gabriella Fabbrocini , 2 Linda Stein Gold , 3 Jerry Tan 1 1. University of Western Ontario and Windsor Clinical Research Inc., Windsor, Ontario, Canada 2. University of Naples Federico II, Naples, Italy 3. Henry Ford Health System, Detroit, Michigan, USA Disclosure: Prof Tan is an advisor, consultant, investigator, and/or speaker for: Almirall, Bausch Health, Boots Walgreens, Botanix, Galderma, Novan, Novartis, and Sun. Prof Fabbrocini reports financial support from Abbvie SRL …

Moffitt Cancer Center asks state to help fund new hospital, expansions | The Business Journals | 9/16/2019

Moffitt is seeking legislation to increase from 4 percent to 10 percent its share of annual cigarette tax money, which would generate an additional $22 million annually. Moffitt currently sees $15.5 million from the tax. The increase to its share of the tax would take place in two phases — one from 4 to 7 percent in 2020 and then to 10 percent in 2023. The two increases would each provide …

Adolescents With Food Allergy Health And Social Care Essay | 9/16/2019

… a utile tool in clinical research.Capsule sum-upThe FAQLQ-TF is the first self-administered, disease-specific HRQL questionnaire for nutrient allergic striplings. It is dependable and valid and hence a utile tool in clinical research in which HRQL is the result of involvement.Key wordsAdolescents EuroPrevall Food allergic reaction Health-related quality of life AdolescentsAbbreviationsHRQL Health-Related Quality of Life FAQLQ-TF Food Allergy Quality of Life Questionnaire Ã¢â …

Carbocisteine inhibits the expression of Muc5b in COPD mouse model | 9/16/2019

… Melinda Thomas Professor Manfred Ogris Yan Song, 1 Wei Wang, 2 Yanqing Xie, 1 Bin Xiang, 1 Xuan Huang, 1 Weijie Guan, 1 Jinping Zheng 1 1 State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, People’s Republic of China; 2 Drug Research Institute of Guangzhou BaiYunShan Pharmaceutical General Factory, Guangzhou, 510515 …

September 14, 2019 | 9/16/2019

… of contraception was illegal then, but Mrs. Sanger fought her case in the courts and eventually won the right to promote her views. She founded the American Birth Control League in 1921 and the Clinical Research Bureau in 1923, and with financial assistance from John D. Rockefeller, Jr., travelled to various foreign countries to promote birth control. Conflict within the ABCL led Mrs. Sanger to leave the organization in 1928 …

Food and Drug Administration

Anaheim Clinical Trials, A CenExel Clinical Research Center of Excellence, Wins Audit “Triple Crown” | Business & Finance | manchestertimes.com | PR Newswire | 9/9/2019

SALT LAKE CITY and ANAHEIM, Calif., Sept. 9, 2019 /PRNewswire/ – CenExel Clinical Research, Inc., (“CenExel” or the “Company”) announced that Anaheim Clinical Trials (ACT), an adult and pediatric Phase I through Phase IV clinical research Center of Excellence, recently underwent three separate routine national agency audits within 45 days. The three agencies responsible for the protection and promotion of public health included the US Food and Drug Administration (FDA); the …

Anaheim Clinical Trials, A CenExel Clinical Research Center of Excellence, Wins Audit “Triple Crown” | BioSpace | 9/9/2019

SALT LAKE CITY and ANAHEIM, Calif. , Sept. 9, 2019 /PRNewswire/ – CenExel Clinical Research, Inc., (“CenExel” or the “Company”) announced that Anaheim Clinical Trials (ACT), an adult and pediatric Phase I through Phase IV clinical research Center of Excellence, recently underwent three separate routine national agency audits within 45 days. The three agencies responsible for the protection and promotion of public health included the US Food and Drug Administration (FDA); the …

Clinical Data

Children’s Tumor Foundation Hosts NF Innovation Week in San Francisco | PRWeb | 9/13/2019

… NF field - will gather at the Google Launchpad for three intensive days (Sep 13-15) to ‘hack’ genomic, research, and imaging/clinical data from the NF Data Portal, and bring their unique insights and experiences to … is critical to consensus building and advancing basic, translational, and clinical research in NF and related fields. Among the key advances to be presented at the NF Conference are: revised diagnostic criteria for all forms …

BC Platforms Provides Complete Data Management Solution for Debiopharm’s Oncology Development Portfolio | PR Newswire | 9/9/2019

… to carry out the consolidation and harmonisation of data, both within Debiopharm internally and also in the future with external clinical research organizations. The goal of the collaboration is to make use of previously untapped … and industry by 2020, providing access to diverse genomic and clinical data and samples from more than 5 million subjects consolidated from a global network of biobanks. Founded in 1997 from an MIT Whitehead project …

Medical Research

Children’s Tumor Foundation Hosts NF Innovation Week in San Francisco | PRWeb | 9/13/2019

… and imaging/clinical data from the NF Data Portal, and bring their unique insights and experiences to help accelerate NF medical research. This event merges the fields of genomic medicine, computer science, statistics, and bioinfomatics … is critical to consensus building and advancing basic, translational, and clinical research in NF and related fields. Among the key advances to be presented at the NF Conference are: revised diagnostic criteria for all forms …

Statins could protect older patients from severe pneumonia, study finds | 9/13/2019

Medical Research Council and published in the American Journal of Respiratory and Critical Care Medicine , was also supported by the NIHR Birmingham Clinical Research Facility. The trial involved 62 patients, aged over 55, who were admitted with community acquired pneumonia with sepsis to Queen Elizabeth Hospital Birmingham between November 2013 and January 2016. The patients were then followed up one year after treatment. The patients were selected at random to …

Biotech

Children’s Tumor Foundation Hosts NF Innovation Week in San Francisco | PRWeb | 9/13/2019

… the most important date on the NF research calendar, and is critical to consensus building and advancing basic, translational, and clinical research in NF and related fields. Among the key advances to be presented at … source data, and an NF platform that attracts pharma and biotech to the NF space, and helps ‘de-risks’ research about a somewhat still relatively not-well-known disease. This is done through the Foundation’s …

The Conference Forum Announces Immuno-Oncology 360° (IO360°) Summit Early 2020 Keynotes and Notable Speakers | PRWeb | 9/12/2019

… biotechs, academia, research organizations, business development and the IO investment community. About the Conference Forum: The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They …

ACA

The ‘serious factor in germline modification | BMJ | 8/27/2019

… clinical research using HGGM, 7 including which diseases it should be used for first. Numerous policy discussions (both national and international) surrounding HGGM refer to the notion of ‘serious’ genetic disease as a core parameter in determining what genetic diseases should be targeted by these technologies and where the line should be drawn. 8–12 For example, in their 2017 Report, the US National Academies of Sciences, Engineering, and Medicine …

James T. Willerson, MD is recognized by Continental Who’s Who | PR Newswire | 8/23/2019

… are going into the profession for the right reasons.” Throughout his education and training, Dr. Willerson graduated from San Antonio Academy, San Antonio, Texas in 1953 and from the Texas Military Institute (TMI), San Antonio … throughout his career including: American Heart Association, American Federation for Clinical Research, Phi Beta Kappa, Alpha Omega Alpha , Diplomate, American Board of Internal Medicine, International Study Group for Research in Cardiac Metabolism, Southern Society of …

NIH

Feds Say Cannabis Researchers Should Just Buy Weed From Legal Dispensaries | 9/11/2019

NIH) and the Food and Drug Administration (FDA) requesting information about their plans to support cannabis research. The senator asked the agencies to detail their clinical research agendas, propose recommendations to improve the “quality and validity of cannabis research,” and to detail the “impacts of regulatory barriers for cannabis research,” Marijuana Moment reports . In response, acting FDA Director Norman Sharpless and NIH Director Francis Collins wrote that they were in …

How to Boost Racial, Ethnic and Gender Diversity in Clinical Research | 9/9/2019

Clinical Research How to Boost Racial, Ethnic and Gender Diversity in Clinical Research Why All Stakeholders Must OWN The Mission Healthcare transformations take time—and the time lag has consequences. It has been 25 years since Congress passed the National Institutes of Health Revitalization Act requiring federally funded clinical research programs to prioritize inclusion of women and minorities. Since then, both the NIH and the Food and Drug Administration have …

National Institutes of Health

CROWN Consortium Receives $5M from National Cancer Institute to Advance Cancer Research across 48 Counties in Wisconsin and Northern Michigan | 9/13/2019

… in Wisconsin and Northern Michigan Share: FOR ANTIGO TIMES Green Bay, Wis. – The National Cancer Institute (NCI), part of the National Institutes of Health (NHI), has awarded the Cancer Research of Wisconsin and Northern Michigan … a team of highly-skilled investigators across many areas of clinical research, including hematology, medical and radiation oncology, palliative care and pediatric oncology. “The National Cancer Institute, the federal government’s principal agency for cancer research …

Cellular Biomedicine Group Hosts Meeting with Investigators to Launch AlloJoin® Knee Osteoarthritis Phase II Clinical Trial | PR Newswire | 9/12/2019

… KOA for this Phase II trial in six leading hospitals in China . About KOA According to the Foundation for the National Institutes of Health, there are 27 million Americans with Osteoarthritis (OA), and symptomatic Knee … proposed new products, services or development thereof, results of our clinical research and development, regulatory infrastructure governing cell therapy and cellular biopharmaceuticals, our ability to enter into agreements with any necessary manufacturing, marketing and/or …

Precision Medicine

Collaboration to develop advanced analytical workflows for clinical labs | 9/11/2019

Thermo Fisher Scientific and Cedars-Sinai have entered into a collaboration to develop a pathway to precision medicine through the development of robust, reliable and sensitive liquid chromatography mass spectrometry (LC-MS)-based workflows for clinical research applications. Bringing together Thermo Fisher’s LC-MS technology with Cedars-Sinai’s physicians and clinical research scientists, this initiative aims to provide clinical research laboratories with specific and sensitive LC-MS-based workflows that …

Penn Medicine Takes a Precision Medicine Approach to Opioid Misuse | HealthIT Analytics | 9/4/2019

The Penn PET Addiction Center of Excellence will combine radiology and psychiatry to combat opioid misuse with precision medicine. Using a five-year, $8.9 million grant from the National Institute on Drug Abuse, psychiatry and … co-principal investigator of the PACE. “We’re combining all the clinical research and expertise at Penn with the technical prowess of our PET program and the PET neuroimaging program at Yale. Additionally, this grant showcases

Clinical Operations

The Conference Forum Announces Immuno-Oncology 360° (IO360°) Summit Early 2020 Keynotes and Notable Speakers | PRWeb | 9/12/2019

… plenaries with data presentations and panel discussions on Discovery and Preclinical Science, Translational Science, Clinical Developments, Bispecifics, Biomarkers and Diagnostics, Clinical Operations, AI for Cancer Immunotherapy, Imaging Aspects, Business Developments, and Emerging Technologies. For the … ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, exchange of ideas and solutions among peers, as …

LabCorp’s Covance Launches Laboratory Data Management Service | Yahoo News | 8/30/2019

… clinical operations capabilities. Significance of the Launch With the latest launch, clinical analytics now includes Laboratory FSPx, which delivers customized global data solutions that enable clients to better manage laboratory data acquisition and site interactions. Clinical operations include clinical research associates and related functions.The company believes that Laboratory FSPx will help customers improve data readiness by assimilating FSPx and central laboratory data teams from study setup to completion. It will …

AMA

Comvita Launches First-Ever Certified UMF™ Manuka-Based Children’s Wellness Line, Comvita Kids | PR Newswire | 8/20/2019

… Amazon, and will roll-out in Whole Foods Markets and select CVS Pharmacies in September. Comvita Launches First-Ever Certified UMF™ Manuka-Based Children’s Wellness Line, Comvita Kids Multiple clinical research studies, supported by preclinical and laboratory research, have shown that honey can reduce the symptoms and discomfort of cough and sore throat. This research has led to leading Public Health Authorities, including the World Health Organization (WHO) , the Centers …

Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor | BMJ | 8/19/2019

… Center , Harvard Medical School , Boston , Massachusetts , USA 2 Laboratory for Statistical and Translational Genetics, Center for Integrative Medical Sciences , RIKEN , Yokohama , Japan 3 Department of Orthopaedic Surgery , Tokyo Women’s Tokyo , Japan 4 Department of Advanced … Japan 7 Institute of Rheumatology , Tokyo Women’s Tokyo , Japan 8 Clinical Research Center , Shizuoka General Hospital , Shizuoka , Japan Chikashi Terao, Laboratory for Statistical and Translational Genetics, Center for Integrative Medical Sciences, Riken, Yokohama 230-0045, Japan …

Pfizer

VC-backed VenatoRx beefs up team with three new hires | PE Hub | 8/21/2019

… started her career as an analytical chemist at Alliance Pharmaceuticals, then moved to leading analytical and CMC project teams at Pfizer, Inc. In her career she has led CMC and Quality groups in the development … Clinical & Medical Affairs at Paratek Pharmaceuticals; Senior Director at Actelion Clinical Research; and Director of Vaccine Research and Clinical Affairs for Infectious Diseases at Wyeth/Pfizer. Dr. McGovern received his B.S. from the University of …

CMAB and Kintor Announce a New Comprehensive Collaboration to Develop and Manufacture the ALK-1 Monoclonal Antibody | PR Newswire | 8/21/2019

… key players in biopharmaceutical industries in Suzhou, China ALK-1 (Activin receptor-like kinase-1) antibody was originally developed by Pfizer who completed two Phase I clinical trials in more than 100 patients with advanced … in China and the United States , with one Phase-III clinical research fully carried out in China as second- and first-line therapies for mCRPC indications and a Phase-II clinical trial being conducted in …

Novartis

Incidence and outcomes of unstable angina compared with non-ST-elevation myocardial infarction | BMJ | 8/21/2019

… manuscript. Funding Swiss National Science Foundation, Swiss Heart Foundation, Cardiovascular Research Foundation Basel, British Heart Foundation Project Grants, Butler Senior Clinical Research Fellowship, New Zealand Heart Foundation Overseas Research Fellowship, Chest Heart and Stroke Scotland … from Abbott, Alere, AstraZeneca, Biomerieux, Boehringer Ingelheim, BMS, Brahms, Cardiorentis, Novartis, Roche, Siemens and Singulex, during conduct of this study. All other authors report no conflicts of interest with this study. Ethics approval This study …

Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor | BMJ | 8/19/2019

… Kyoto University Graduate School of Medicine Faculty of Medicine , Kyoto , Japan 7 Institute of Rheumatology , Tokyo Women’s Tokyo , Japan 8 Clinical Research Center , Shizuoka General Hospital , Shizuoka , Japan Chikashi Terao, Laboratory for Statistical and Translational … Inc., Takeda Pharmaceutical, Eisai, Nippon Shinyaku, YL Biologics Ltd., AbbVie, Novartis Pharmaceutical K.K., Kaken Pharmaceutical Co., Ltd., UCB Japan, Ono Pharmaceutical Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Teijin Pharma, Torii Pharmaceutical Co., Ltd. and …

Merck

Epizyme Announces Board of Director Appointments to Support Continued Evolution and Growth | Business Wire | 9/4/2019

… their medications. These businesses included data and informatics, health economics and outcomes research, reimbursement hub services and the US Oncology clinical research business units. Before that, he was senior vice president of sales and marketing … director and department head of cancer biology and therapeutics at Merck & Co., Inc., and before that, was a co-founder at Aton Pharma, Inc. Dr. Richon began her scientific career as a postdoctoral fellow in …

Global Flow Cytometry Market is Expected to Reach USD 8.59 Billion by 2025 : Fior Markets | Globe Newswire | 9/3/2019

… accurate results and requires less time at the same cost. The flow cytometry technology is widely used in academic and clinical research, and diagnosis of diseases such as cancer, HIV, and hematological malignancies. Increasing cases … Sony Biotechnology, Becton, Dickinson and Company, Miltenyi Biotec, Biomérieux S.A., Merck KGaA, Bio-Rad Laboratories, Cytonome St, Enzo Life Sciences, Luminex and others. Key players active in the market are involved in the collaborative agreements …

IQVIA

Global Clinical Research Services Procurement: 2019 Market Intelligence Report - ResearchAndMarkets.com | Business Wire | 9/9/2019

DUBLIN- The “Global Clinical Research Services - Procurement Market Intelligence Report” report has been added to ResearchAndMarkets.com’s offering. The spend momentum for this market is attributed to the increase in R&D expenditure to cater to … metrics PART 10: Suppliers Under Coverage Overview Supplier positioning Profile: IQVIA Profile: PAREXEL International Profile: Laboratory Corporation of America Profile: ICON Profile: PRA Health Sciences Profile: Pharmaceutical Product Development PART 11: US Market Insights Category

Senior Clinical Research Associate, Oncology (Home-based, Central) - IQVIA Biotech (R1093656) - Morrisville, NC, , USA #jobs #Morrisville pls RT | 9/9/2019

Job Detail for Senior Clinical Research Associate, Oncology (Home-based, Central) - IQVIA Biotech (R1093656) Job Location: IQVIA Holdings, Morrisville, NC, , USA Job Detail for Senior Clinical Research Associate, Oncology (Home-based, Central) - IQVIA Biotech (R1093656) Job Location: IQVIA Holdings, Morrisville, NC, , USA Jobs In Senior Clinical Research Asso… Jobs In Senior Clinica… Jobs In Senior Cl… Job Description IQVIA is the leading human data science company focused on helping healthcare …

Cerner

Mayo Clinic, Cerner expand into UK with new Oxford partnership | Healthcare IT News | 9/3/2019

Mayo Clinic Healthcare in partnership with Oxford University Clinic will use Cerner technology to help enable more proactive health management, more coordinated care and better health outcomes. September 03, 2019 01:45 PM The Mayo Clinic … expertise, and that of the three provider organisations, to improve clinical research and uncover new insights that could be applied to the wider UK health system. THE LARGER TREND Mayo Clinic’s flagship U.S. health system

Global $27.8Bn Healthcare Cloud Computing Market Outlook to 2026 - Led by AthenaHealth, Cerner, Carecloud, Carestream, Epic Systems, Dell, and Sectra | Globe Newswire | 8/22/2019

Cerner Corporation, CareCloud Corporation, Carestream Corporation, Epic Systems Corporation, Dell Inc., and Sectra AB. Companies are forming various strategic alliances with clinical research organizations and medical devices companies to further expand their profit margins in the healthcare IT sector. These type of strategic collaborations are expected to aid market growth in the coming years. Key Topics Covered …

Apple Health

Kaiser Permanente Reduces Secondary Cardiac Events Through Virtual Cardiac Rehabilitation Program | PR Newswire | 8/29/2019

OAKLAND, Calif. , Aug. 28, Kaiser Permanente has demonstrated promising results in reducing secondary cardiac events and rehospitalizations by creating a virtual cardiac rehabilitation program that fits seamlessly into patients’ lives. Increasing rates of program enrollment and completion have been key factors in the improved outcomes. Results and details about the program were published today in NEJM Catalyst. Cardiovascular disease is the leading cause of death in the United States 1 …

Allscripts Joins Apple Health Records, Boosts Patient Data Access | Patient Engagement HIT | 8/28/2019

Patient Data Access News Allscripts Joins Apple Health Records, Boosts Patient Data Access The move will expand the number of participants granting patient data access and access to Apple Health Records. Source: Thinkstock By August … care provider’s electronic health record, and increase their participation in clinical research,” said the researchers, who hailed from the University of California in San Diego and San Francisco. “However, because this capability is new, few

MCRA

Ortho RTI Selects MCRA for Phase I/II Rotator Cuff Repair Human Trial | 9/13/2019

By: BONEZONE Ortho Regenerative Technologies (Ortho RTI) chose MCRA as its U.S.-based orthopedic specialty clinical research organization to conduct its Phase I/II human trial of rotator cuff repair with Ortho-R. The clinical trial will enroll 75 patients, randomized into three arms of 25 patients across multiple sites in the U.S. The disclosure of pivotal preclinical results will occur within 2019, followed by the filing of an Investigational …

Ortho Regenerative Technologies selects US based specialized CRO, MCRA LLC, for its upcoming phase I/II rotator cuff human trial | Benzinga | 9/12/2019

MONTREAL , Sept. 12, 2019 /CNW/ - Ortho Regenerative Technologies Inc . (CSE: ORTH ) (“ Ortho RTI “ or the “ Company “), an emerging Orthobiologics company, announced today that it has selected MCRA, LLC as its US based orthopedic specialty clinical research organization (“CRO”), to conduct its upcoming Phase I/II rotator cuff Ortho-R human trial. Ortho-R utilizes Ortho RTI’s proprietary RESTORE technology platform, which consists of a muco-adhesive CHITOSAN based biopolymer matrix …

Parexel

Global Clinical Trial Management Systems (CTMS) Market to 2024 - Veeva Vault CTMS Gains Prominence - ResearchAndMarkets.com | Business Wire | 8/13/2019

… eResearch Technology, Inc. (USA) IBM Watson Health (USA) MedNet Solutions (USA) Medidata Solutions (USA) Nextrials, Inc. (USA) Oracle Corp. (USA) PAREXEL International Corp. (USA) Trial By Fire Solutions, LLC (USA) Veeva Systems, Inc. (USA) Winchester … Platform & Mobile Health Capabilities to Techfields Pharma ICON Takes Over Clinical Research Management Biomedical Systems Partners with Foundry Health Medidata Cloud Technology Chosen to Support Biogen Clinical Trials UPS Expands Healthcare-Specific Capabilities to Support …

Datavant, PCORnet to build real-world data network spanning 60M patients | FierceBiotech | 8/13/2019

… Centered Research Foundation (PCRF) tapped Datavant to help it de-identify and coordinate the sharing of data across its national clinical research network covering over 60 million patients. More than 70 healthcare institutions make up … world data pilot project focused on neurodegenerative diseases and with Parexel on using such data to help design clinical trials and accrue participants …

Veeva

Suvoda Partners With Veeva to Offer Seamless IRT for Veeva Vault EDC | PRWeb | 9/9/2019

Suvoda Partners With Veeva to Offer Seamless IRT for Veeva Vault EDC Share Article Suvoda announces new technology partnership with Veeva Systems that will help streamline clinical trials CONSHOHOCKEN, Pa. Suvoda LLC , a SaaS provider … offering exceptional customer and advisory services to biopharmaceutical companies and clinical research organizations of all sizes. Learn more at http://www.suvoda.com . Share article on social media or email: View article via

Electronic Trial Master File (ETMF) Systems Market Worth $1.8 Billion by 2024 - Exclusive Market Report by M&M | PR Newswire | 8/26/2019

… clinical research and a large number of clinical trials. Several major global players are also based in the US, owing to which the country has become a center of innovation in the eTMF Systems Market Get 10% Customization Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=94357456 Veeva Systems (US), Oracle Corporation (US), Phlexglobal Limited (UK), TransPerfect Global Inc. (US), Aurea Software (US), LabCorp (US), ePharmaSolutions (US), Wingspan Technology, Inc. (US), MasterControl …

Datavant

Democratic jousting on health tech issues - POLITICO | 8/14/2019

… near and dear to health technology, with rural broadband and “Medicare for All” getting play. — Gov tech deals: Tech companies Datavant and Syapse landed deals to help the government’s health data push. — Euro regulations: And … the 70-plus hospital system, 60 million-patient Patient Centered Clinical Research Network, or PCORNET, according to an announcement Tuesday. The agreement will speed up the consortium’s comparative effectiveness research by providing a tool to …

Datavant partners with the People-Centered Research Foundation to de-identify and link data across national clinical research network | PR Newswire | 8/13/2019

SAN FRANCISCO Datavant announced today its selection by the People-Centered Research Foundation (PCRF) to de-identify and link patient data across PCORnet, the National Patient-Centered Clinical Research Network. PCRF is the central office for PCORnet, which has been developed with funding from the Patient-Centered Outcomes Research Institute (PCORI) and consists of more than 70 top academic medical centers, community hospitals, clinics, and health plans; as well as …

Harvard Medical School

Presymptomatic Serum Neurofilament Light Chain Levels Before Multiple Sclerosis | 9/13/2019

September 13, 2019 Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis Author Affiliations Article Information 1 Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts 2 Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland 3 Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Boston, Massachusetts 4 Department of Neurology, Harvard Medical School

World Leading Mental Health Experts Join SilverCloud Health’s Expanded Clinical Advisory Board | PR Newswire | 9/12/2019

… and over 75 books and clinical manuals, mostly in the areas of anxiety and related emotional disorders, sexual problems, and clinical research methodology. Professor Farchione is a research professor at Boston University and directs the … the Joslin Diabetes Center in Boston , a faculty member at Harvard Medical School and Chairman of the National Certification Board for Diabetes Educators. Professor Taylor is a research professor and director of the Center for …

HCA

HealthCarePoint Establishes BlueCloud Europe, Expanding Investigator Sites’ Ability to Connect with Sponsors, CROs, Universities and Other Industry Stakeholders Worldwide | PRWeb | 8/27/2019

BlueCloud® by HealthCarePoint (HCP) has expanded to Europe with major site networks recently adopting BlueCloud Systems, including Hospital La Paz Institute for Health Research in Madrid, Spain, the Slovak Research Center (SRCSK) in Trencin, Slovakia … of 1.6 million healthcare professionals from thousands of healthcare and clinical research organizations. Tigran Arzumanov, BlueCloud Europe manager, explains, “BlueCloud is a unique network, built not only to make clinical research and healthcare more efficient

Private equity companies acquire virtual research firm Thread | MedCity News | 8/27/2019

… of the deal were not disclosed. However, Thread said it would use the investment - from JLL Partners and Water Street Healthcare Partners - to accelerate the expansion of its service offering globally. Post a comment / at … and sensors. “We’re excited to expand Thread’s platform to modernize clinical research for our customers, participants and sites,” said John Reites, Thread’s chief product officer, in a statement. “This partnership will further our commitment to …

Mayo Clinic

Mayo Clinic, Google partner to use AI, patient data to catapult research | 9/11/2019

Google Cloud and Mayo Clinic are working together to improve patient outcomes, transform clinician experiences, support clinical research and revolutionize healthcare delivery. Google brings its cloud platform and artificial intelligence capabilities, while Mayo brings its clinical expertise and a strategy to advance the diagnosis and treatment of disease. “When selecting a technology partner, Mayo was looking for an organization with the engineering talent, focus and cloud technology to collaborate with …

Mayo Clinic, Cerner expand into UK with new Oxford partnership | Healthcare IT News | 9/3/2019

Mayo Clinic Healthcare in partnership with Oxford University Clinic will use Cerner technology to help enable more proactive health management, more coordinated care and better health outcomes. September 03, 2019 01:45 PM The Mayo Clinic … expertise, and that of the three provider organisations, to improve clinical research and uncover new insights that could be applied to the wider UK health system. THE LARGER TREND Mayo Clinic’s flagship U.S. health system

Massachusetts General Hospital

Presymptomatic Serum Neurofilament Light Chain Levels Before Multiple Sclerosis | 9/13/2019

Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland 3 Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Boston, Massachusetts 4 Department of Neurology, Harvard Medical School, Boston, Massachusetts 5 Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts 6 Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland 7 Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts 8 Channing …

Alpha Tau Medical Appoints Jefferson University Radiation Oncologist Robert Den as Chief Medical Officer | PR Newswire | 9/4/2019

… Medical Officer (CMO). In his new role, and as a prominent expert and accomplished clinician, Dr. Den will lead the clinical research functions for Alpha Tau, furthering the company mission of innovation in cancer therapy … Harvard Medical School in 2006. He performed his internship at Massachusetts General Hospital and residency at Thomas Jefferson University. Today, he treats a wide array of tumors, with particular focus on genitourinary and gynecologic malignancies …

Ascension

CROWN Consortium Receives $5M from National Cancer Institute to Advance Cancer Research across 48 Counties in Wisconsin and Northern Michigan | 9/13/2019

Ascension Wisconsin and Aspirus, Inc. Together, these organizations offer an experienced research infrastructure with a team of highly-skilled investigators across many areas of clinical research, including hematology, medical and radiation oncology, palliative care and pediatric oncology. “The National Cancer Institute, the federal government’s principal agency for cancer research and training, funds grants that undergo a rigorous peer review process to ensure that the most promising research may be funded …

Aspirus part of group to receive $5 million grant for cancer research | Press Room | Aspirus Health Care | 9/11/2019

Ascension Wisconsin and Aspirus, Inc. Together, these organizations offer an experienced research infrastructure with a team of highly-skilled investigators across many areas of clinical research, including hematology, medical and radiation oncology, palliative care and pediatric oncology. “The National Cancer Institute, a leader in the fight against cancer across the nation and around the world, has very high standards for grant eligibility,” said Dr. Anthony Jaslowski, Principal Investigator of the …

MD Anderson Cancer Center

Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2019 | PR Newswire | 8/17/2019

… Our third important development during the quarter was the announcement that our ongoing sponsored research at The University of Texas MD Anderson Cancer Center resulted in the discovery that Annamycin, our lead drug candidate for … using Poland trial data 2020 (Fast Track Approved) Announce additional clinical research in lung and metastatic lung cancers 2020 Immune/Transcription Modulators - WP1066 Family Clinical Trials WP 1066 - Announcement of initial clinical data from WP1066 …

Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2019 | Markets Insider | Business Insider | 8/16/2019

… Our third important development during the quarter was the announcement that our ongoing sponsored research at The University of Texas MD Anderson Cancer Center resulted in the discovery that Annamycin, our lead drug candidate for … using Poland trial data 2020 (Fast Track Approved) Announce additional clinical research in lung and metastatic lung cancers 2020 Immune/Transcription Modulators - WP1066 Family Clinical Trials WP 1066 - Announcement of initial clinical data from WP1066 …

University of Missouri Health Care

Cerner, Duke to Automate Data Collection for Chronic Disease Care | HealthIT Analytics | 8/9/2019

Cerner, Duke to Automate Data Collection for Chronic Disease Care Cerner and Duke have partnered to innovate clinical research registries and evaluate potential treatments for chronic disease. Source: Thinkstock 09, 2019 - Cerner has partnered with … use Cerner technology to analyze de-identified data from the University of Missouri Health Care and Ascension Seton, in partnership with Dell Medical School at the University of Texas at Austin, with the goal of

Cerner, Duke create Learning Health Network to automate data for research | Healthcare IT News | 8/8/2019

… sciences, pharmaceuticals and healthcare have easier access to aggregated data. August 08, 2019 12:15 PM Cerner, in collaboration with Duke Clinical Research Institute, will launch the Cerner Learning Health Network, which aims to automate data … disease. It will analyze de-identified patient data from the University of Missouri Health Care and Ascension Seton, in partnership with Dell Medical School at The University of Texas at Austin, with the goal of …

University of Texas MD Anderson Cancer Center

Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2019 | PR Newswire | 8/17/2019

… been the case.” “Our third important development during the quarter was the announcement that our ongoing sponsored research at The University of Texas MD Anderson Cancer Center resulted in the discovery that Annamycin, our lead … using Poland trial data 2020 (Fast Track Approved) Announce additional clinical research in lung and metastatic lung cancers 2020 Immune/Transcription Modulators - WP1066 Family Clinical Trials WP 1066 - Announcement of initial clinical data from WP1066 …

Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2019 | Markets Insider | Business Insider | 8/16/2019

… been the case.” “Our third important development during the quarter was the announcement that our ongoing sponsored research at The University of Texas MD Anderson Cancer Center resulted in the discovery that Annamycin, our lead … using Poland trial data 2020 (Fast Track Approved) Announce additional clinical research in lung and metastatic lung cancers 2020 Immune/Transcription Modulators - WP1066 Family Clinical Trials WP 1066 - Announcement of initial clinical data from WP1066 …

Mount Sinai Hospital

Sweating, chafing, chlorine: Solutions to summer’s biggest … | NBC News | 8/18/2019

… clinical research of dermatology at Mount Sinai Hospital in New York City, points out, sweat — especially in summer months — is simply unavoidable. “Our body sweats to help maintain its core temperature, with production typically increasing as we warm up due to a rise in outside temperature or an increased exertion of energy forcing the body to work harder,” Dr. Zeichner explains. It’s also (for the most part) uncontrollable. “It’s wired …

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus | BMJ | 8/12/2019

… 13 Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona , Barcelona , Spain 14 Medicine , Toronto Western Hospital, University Health Network, Mount Sinai Hospital, University of Toronto, Toronto Scleroderma Research Program , Toronto , Ontario , Canada 15 Center … Internal Medicine , Medical University of Graz , Graz , Austria 42 Lupus Clinical Research Program, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases , National Institutes of Health , Bethesda , Maryland , USA 43 …

AHN

Hypolipidaemia among patients with PMM2-CDG is associated with low circulating PCSK9 levels: a case report followed by observational and experimental studies | BMJ | 8/24/2019

… Sick Children , Toronto , Ontario , Canada 4 Department of Paediatrics , University of Toronto , Toronto , Ontario , Canada 5 Department of Biochemical Neuroendocrinology , Clinical Research Institute of Montreal , Montreal , Quebec , Canada 6 Service de Biochimie et Biologie Moléculaire … Clinical Research Institute of Montreal, Montreal, QC H2W 1R7, Canada; seidahn{at}ircm.qc.ca Abstract Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are novel therapeutics for reducing low-density lipoprotein cholesterol (LDLc). While serious …

Health Net

Cerner Partnership to Boost Care Access for Senior Patients | EHR Intelligence | 8/19/2019

Clinical Research Institute (DCRI) to develop the Cerner Learning Health Network, which will help clinicians more easily use EHR data insights to guide better-informed care. “Collaborating with the DCRI on the Learning Registry to pilot the Cerner Learning Health Network is an exciting step forward in improving the health of those living with chronic cardiovascular disease,” said Cerner Strategic Growth Senior Vice President Art Glasgow. “At Cerner, we’re committed …

FDA partners with Syapse to study regulatory use of real-world evidence | Healthcare IT News | 8/15/2019

… patient-reported outcomes data into RWE sets. THE LARGER TREND Syapse says it will also engage oncologists in its Learning Health Network in joint outcomes research, enabling the use of real-world evidence by oncology … innovation. And earlier this month, Cerner, in collaboration with Duke Clinical Research Institute, launched its new Cerner Learning Health Network , which aims to automate data collection from multiple sources, including electronic health records. The goal …

Travis May

Democratic jousting on health tech issues - POLITICO | 8/14/2019

Clinical Research Network, or PCORNET, according to an announcement Tuesday. The agreement will speed up the consortium’s comparative effectiveness research by providing a tool to quickly de-identify data needed to link datasets for studies, said Datavant CEO Travis May. Up until now, de-identification in the consortium has been done on a one-off basis. The company’s software scrubs out explicit information like date of birth and Social Security …

Datavant partners with the People-Centered Research Foundation to de-identify and link data across national clinical research network | PR Newswire | 8/13/2019

… by the People-Centered Research Foundation (PCRF) to de-identify and link patient data across PCORnet, the National Patient-Centered Clinical Research Network. PCRF is the central office for PCORnet, which has been developed with … important work that the PCORnet network partners are doing,” said Travis May , Co-founder and Chief Executive Officer of Datavant. “We share the common mission of unlocking the power of health data to answer the …

Frank Jiang

CStone completes registration filing for the Phase I trial of CDK4/6 inhibitor CS3002 in Australia and will soon initiate the study | PR Newswire | 8/23/2019

… improved tumor suppressing activities compared to monotherapies. In addition, CS3002 has also demonstrated potentially favorable safety and tolerability profiles. Dr. Frank Jiang , Chairman and CEO of CStone, commented: “Currently, there are several CDK4/6 inhibitors that … class management team with extensive experience in innovative drug development, clinical research, and commercialization. The company has built an oncology-focused pipeline of 15 drug candidates with a strategic emphasis on immuno-oncology combination therapies …

CStone completes registration filing for the Phase I trial of CDK4/6 inhibitor CS3002 in Australia and will soon initiate the study | Markets Insider | Business Insider | 8/22/2019

… improved tumor suppressing activities compared to monotherapies. In addition, CS3002 has also demonstrated potentially favorable safety and tolerability profiles. Dr. Frank Jiang , Chairman and CEO of CStone, commented: “Currently, there are several CDK4/6 inhibitors that … class management team with extensive experience in innovative drug development, clinical research, and commercialization. The company has built an oncology-focused pipeline of 15 drug candidates with a strategic emphasis on immuno-oncology combination therapies …

Ian Rentsch

India’s Jehangir Clinical Development Centre to join Clinerion’s global network of partner hospitals | Healthcare IT News | 8/19/2019

… at JCDC are delighted about partnering with Clinerion as there is an ideal alignment of Clinerion’s innovative technology and our clinical research expertise,” said Pathik Divate, Chief Executive Officer, JCDC. “We are excited about harnessing … patients which reflects the diversity of the world, itself,” said Ian Rentsch, Chief Executive Officer, Clinerion. Topics …

Jehangir Clinical Development Centre (JCDC), the Research Arm of Jehangir Hospital, Is the First Hospital in India to Join Clinerion’s Patient Network Explorer Platform | PRWeb | 8/15/2019

… at JCDC are delighted about partnering with Clinerion as there is an ideal alignment of Clinerion’s innovative technology and our clinical research expertise,” says Pathik Divate, CEO of the JCDC. “We are excited about harnessing … patients which reflects the diversity of the world, itself,” says Ian Rentsch, CEO of Clinerion. About Clinerion Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of …

Mark Hanley

VirTrial Partners with ACRP to Provide ‘Virtual Trial Capable’ Training and Certificate Program Free to ACRP Members | Business & Finance | manchestertimes.com | Business Wire | 8/19/2019

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Aug 19, 2019– VirTrial today announced a training and certificate program to help clinical research professionals prepare for hybrid decentralized clinical trials (DCT) which include a combination of virtual and in … supporting clinical research professionals and site sustainability,” said VirTrial CEO, Mark Hanley. “We are turning the threat of site-less trials into an opportunity by embracing technology and providing training for clinical researchers on how

Stuart Titus

Medical Marijuana, Inc. Listed as a Top 5 Company in Hemp-Based CBD Market by Equity Research Firm Avise Analytics | PR Newswire | 8/22/2019

… be recognized as a leader in the cannabis industry and specifically the CBD market,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus . “Our company has continued to advocate for safe and legal CBD access across … cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its internal R&D and scientific team and its pharmaceutical investment companies and partners including AXIM …

Medical Marijuana, Inc. and Subsidiary Kannaway® Honored as Stevie® Award Winners in 2019 International Business Awards® | PR Newswire | 8/20/2019

… all aspects of the CBD industry since new management took control in March 2011 ,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus . “From product innovation and development to laboratory testing, the Company has set many … cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its internal R&D and scientific team and its pharmaceutical investment companies and partners including AXIM …

Daniel O’Day

Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration Brussels Stock Exchange:GLPG | Globe Newswire | 8/24/2019

… are excited to close this unique agreement, which will generate both long-term strategic value and mutual, immediate benefits,” said Daniel O’Day, Chairman and Chief Executive Officer of Gilead. “The collaboration reflects Gilead’s intent to … approval requirements (including that data from the ongoing and planned clinical research programs may not support registration or further development of its candidate products due to safety, efficacy or other reasons), Galapagos’ reliance on collaborations …

Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration | Business Wire | 8/23/2019

FOSTER CITY, Calif. & MECHELEN, Belgium- Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced the closing of the global research and development collaboration agreement signed on July 14, 2019. This agreement has received clearance from the U.S. Federal Trade Commission under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and merger control approval from the Austrian Federal Competition Authority. Under the terms of the agreement …

Greg Koski

ACRES Launches Global Accreditation of Clinical Research Sites | Markets Insider | Business Insider | 7/23/2019

SUDBURY, Mass. , July 23, 2019 /PRNewswire-PRWeb/ – The Alliance for Clinical Research Excellence and Safety (ACRES), a public-interest multi-stakeholder collaborative building a global-system to enhance quality and effectiveness of medicines development globally … accomplishment is truly extraordinary.” ACRES co-founder and CEO, Dr. Greg Koski , further praised the SASI Team and Kennedy, saying “When ACRES first announced in Copenhagen nearly a decade ago its intention to create a

Mike Nolte

Signant Health Appoints Todd Everhart as Clinical Vice President to Accelerate Intelligent eCOA and Predictive Data Analytics in Medical Clinical Research | PR Newswire | 8/20/2019

… intelligent eCOA, rater training, predictive analytics and other data quality monitoring products outside of CNS disorders. Speaking on this appointment, Mike Nolte , CEO of Signant Health, said, “Biopharmaceutical sponsors’ focus on complex indications continues to … experienced team.” Signant is a global technology company that accelerates clinical research and improves the experience of patients accessing potentially life-changing therapies. Its solutions, combined with deep scientific and clinical insight, link engaged patients …

Introducing Signant Health [Formerly CRF Bracket] and the Industry’s Most Comprehensive Patient-Centric Suite for Clinical Research | PR Newswire | 6/10/2019

… clinical research succeeds in the background,” said Mike Nolte , CEO of Signant Health. “We work to be expert, with proven solutions and scientific support that simplify research for patients, sponsors and CROs. I’m humbled to be a part of our customers’ important work, proud of the Signant Health team and excited to continue to innovate along every step of the patient journey.” Signant Health combines a comprehensive, united suite of …

Michael J. Hennessy Jr.

MD Magazine® Launches ‘Expert Perspectives on Diagnosis and Treatment of Irritable Bowel Syndrome’ | Business & Finance | manchestertimes.com | Business Wire | 6/26/2019

… patients with irritable bowel syndrome experience mild to severe symptoms that may come and go and change over time,” said Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of MD Magazine ®. “During … and director of Health Services Research in Academic Affairs and Clinical Research at Cedars-Sinai. The “Peer Exchange” series begins with an overview of IBS, including its signs and symptoms. The experts also discuss the …

MD Magazine® Launches “Identifying the Biomarkers for the Treatment of Severe Asthma” Video Series | Business Wire | 4/11/2019

… https://www.businesswire.com/news/home/20190411005784/en/ “The biologics market for treating asthma has significantly increased in the last two decades,” Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of MD Magazine ®. “During … the pulmonary medicine department and the director of the Airways Clinical Research Center at Baylor College of Medicine and director of the Asthma and COPD Clinic at Ben Taub Hospital ; Bradley E. Chipps, M.D., board …

Fred Hutchinson

Life Science Washington Announces 2019 Inductees into the Washington Life Science Hall of Fame | Business Wire | 4/23/2019

Fred Hutchinson Cancer Research Center Clinical Research Division, where she also held the Madeline Dabney Adams Endowed Chair in AML Research and was the principal investigator of an active, NIH-funded laboratory. In 2006, she established and became the Director of the Cord Blood Transplant Program at the Fred Hutch/Seattle Cancer Care Alliance, which has grown to be one of the leading programs in the country and the coordinating …

Staff Scientist, Immunotherapy | Nature | 12/28/2017

Facebook Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV / AIDS and … Trials Network. Careers Start Here. The Program of Immunology and Clinical Research Division is seeking an enthusiastic scientist to work in the pre-clinical research laboratory environment. The Program in Immunology is a leader in